March 18 (Reuters) - Madrigal Pharmaceuticals said on Monday it has commenced an underwritten public offering of $500 million in shares of its common stock and pre-funded warrants to purchase common stock. (Reporting by Mariam Sunny in Bengaluru)
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
206.1 USD | -5.42% | -1.55% | -10.40% |
May. 07 | Sector Update: Health Care Stocks Steady Pre-Bell Tuesday | MT |
May. 07 | Madrigal Pharmaceuticals Q1 Loss Widens; Shares Fall Pre-Bell | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.40% | 4.64B | |
+3.57% | 106B | |
+7.13% | 23.47B | |
-13.99% | 21.9B | |
-6.50% | 18.77B | |
-37.26% | 17.85B | |
-7.71% | 16.78B | |
+7.01% | 14.41B | |
+39.09% | 12.86B | |
+324.18% | 8.78B |
- Stock Market
- Equities
- MDGL Stock
- News Madrigal Pharmaceuticals, Inc.
- Madrigal commences $500 million public offering of common stock